Throughout the last decade, more than 300,000 healthcare-based, mobile applications have been created for patients to help address specific health issues. However, there’s no way to ensure patients and physicians mobile apps are safe and effective ways to help treat any condition.
In a viewpoint article recently published in JAMA, Brigham and Women’s Hospital and Harvard Medical School physicians David W. Bates, MD, Adam Landman, MD, and David M. Levine, MD, argue the Food and Drug Administration (FDA) should develop regulatory policies that ensure the safety and effectiveness of mobile apps.
“Substantial gaps exist today between what the marketplace is producing in terms of apps and what is needed to make care better,” the authors wrote. “Specific approaches can be taken at the FDA and at federal agencies that support research and encourage redirection.”